Faculty, Staff and Student Publications
Publication Date
12-1-2022
Journal
Cancer Prevention Research
Abstract
Our results show that everolimus delays mammary tumor formation in multiple mouse models, suggesting that mTOR inhibitors will be useful for the prevention of ER-negative and triple-negative breast cancer in humans. See related Spotlight, p. 787.
Keywords
Humans, Mice, Animals, Female, Receptors, Estrogen, TOR Serine-Threonine Kinases, Mammary Neoplasms, Animal, Everolimus, Breast Neoplasms
DOI
10.1158/1940-6207.CAPR-22-0106
PMID
35981902
PMCID
PMC9762336
PubMedCentral® Posted Date
August 2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons
Comments
Supplementary Material
PMID: 35981902